Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 7, 2012, Pages 755-762

  Morrow, Richard L ^a   Garland, E Jane ^b   Wright, James M ^a   Maclure, Malcolm ^a,c   Taylor, Suzanne ^a   Dormuth, Colin R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MINISTRY OF HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE;

AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CANADA; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEASONAL VARIATION; SEX RATIO;

EID: 84859589719     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111619     Document Type: Article

References (24)

1. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. MMWR Morb Mortal Wekly Rep 2010;59:1439-43.
2. Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital Health Stat 10 2008;Jul:1-14.
3. Nigg J, Nikolas M, Burt SA. Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010;49:863-73.
4. Thapar A, Langley K, Asherson P, et al. Gene-environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective. Br J Psychiatry 2007; 190: 1-3. (Pubitemid 46121493)
5. Liederman J, Flannery KA. Fall conception increases the risk of neurodevelopmental disorder in offspring. J Clin Exp Neuropsychol 1994;16:754-68. (Pubitemid 24331915)
6. Mick E, Biederman J, Faraone SV. Is season of birth a risk factor for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 1996;35:1470-6. (Pubitemid 26360932)
7. Seeger G, Schloss P, Schmidt MH, et al. Gene-environment interaction in hyperkinetic conduct disorder (HD + CD) as indicated by season of birth variations in dopamine receptor (DRD4) gene polymorphism. Neurosci Lett 2004;366:282-6. (Pubitemid 39024282)
8. Brookes KJ, Neale B, Xu X, et al. Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 94-9.
9. Atladóttir HO, Parner ET, Schendel D, et al. Variation in incidence of neurodevelopmental disorders with season of birth. Epidemiology 2007;18:240-5.
10. Tochigi M, Okazaki Y, Kato N, et al. What causes seasonality of birth in schizophrenia? Neurosci Res 2004;48:1-11 (Pubitemid 37543764)
11. Hebert KJ, Miller LL, Joinson CJ. Association of autistic spectrum disorder with season of birth and conception in a UK cohort. Autism Res 2010;3:185-90.
12. Kolevzon A, Weiser M, Gross R, et al. Effects of season of birth on autism spectrum disorders: Fact or fiction? Am J Psychiatry 2006; 163:1288-90 (Pubitemid 44464462)
13. Hauschild KM, Mouridsen SE, Nielsen S. Season of birth in Danish children with language disorder born in the 1958-1976 period. Neuropsychobiology 2005;51:93-9. (Pubitemid 40522801)
14. Elder TE. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ 2010; 29: 641-56.
15. Evans WN, Morrill MS, Parente ST. Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. J Health Econ 2010;29:657-73.
16. Bedard K, Dhuey E. The persistence of early childhood maturity: international evidence of long-run age effects. Q J Econ 2006; 121:1437-72. (Pubitemid 44888178)
17. Cobley S, Baker J, Wattie N, et al. Annual age-grouping and athlete development: a meta-analytical review of relative age effects in sport. Sports Med 2009;39:235-56.
18. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8 (Pubitemid 46972911)
19. Scheffler RM, Hinshaw SP, Modrek S, et al. The global market for ADHD medications. Health Aff (Millwood) 2007;26:450-7
20. Dormuth CR, Glynn RJ, Neumann P, et al. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther 2006;28:964-78, discussion 2-3.
21. Humphries KH, Rankin JM, Carere RG, et al. Co-morbidity data in outcomes research: Are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol 2000;53:343-9. (Pubitemid 30216472)
22. Steele LS, Glazier RH, Lin E, et al. Using administrative data to measure ambulatory mental health service provision in primary care. Med Care 2004;42:960-5. (Pubitemid 39530791)
23. Gould MS, Walsh BT, Munfakh JL, et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166: 992-1001.
24. Levy F, Hay DA, McStephen M, et al. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36:737-44. (Pubitemid 27250436)